American pharmaceutical Moderna on Monday announced it would provide 500 million doses of its Covid-19 shot to Covax—the World Health Organization’s vaccine sharing program that is in desperate need of supply—though the bulk of the doses will not be available until 2022.

Stay Connected
Forbes on Facebook:
Forbes Video on Twitter:
Forbes Video on Instagram:
More From Forbes:

Moderna Pledges 500 Million Vaccine Doses To Stumbling WHO Program | Forbes